Colin Sandercock Steps Down as Senior Vice President, General Counsel and Secretary of Cue Biopharma

Colin Sandercock left the role of Senior Vice President, General Counsel and Secretary at Cue Biopharma on June 1, 2026, according to an SEC filing.

Cue Biopharma reported that Colin Sandercock was succeeded as Senior Vice President, General Counsel and Secretary by Sumita Ray on June 1, 2026. He continues with the company as Senior Vice President, Intellectual Property. (Source: an SEC filing.)

More legal leadership moves at Cue Biopharma

• Sumita Ray Named Chief Legal & Compliance Officer and Corporate Secretary of Cue Biopharma (June 1, 2026)

Other general counsel moves in June 2026

• Michael Listgarten Named General Counsel of ALX Oncology (June 30, 2026)
• Valerie Barnett Steps Down as Chief Legal Officer and Corporate Secretary of Cytek Biosciences (June 29, 2026)
• Lucy Fato Steps Down as Executive Vice President, General Counsel and Corporate Secretary of Seaport Entertainment Group (June 25, 2026)
• Dean Manson Steps Down as Chief Legal Officer and Secretary of EchoStar (June 23, 2026)
• Kelly B. Rose Steps Down as Senior Vice President, Legal, General Counsel and Corporate Secretary of ConocoPhillips (June 23, 2026)
• K. Harold Fletcher Named Chief Legal and Strategy Officer and Corporate Secretary of Celularity (June 19, 2026)
• Andrew C. Carington Steps Down as Senior Vice President, General Counsel and Secretary of Hamilton Beach Brands Holding Company (June 18, 2026)
• Chip Keller Named Chief Legal Officer and Corporate Secretary of Fidelity National Information Services (June 16, 2026)

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.